CONMED Profit Margin 2006-2019 | CNMD

Current and historical gross margin, operating margin and net profit margin for CONMED (CNMD) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. CONMED net profit margin as of March 31, 2019 is 3.56%.
CONMED Annual Profit Margins
CONMED Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.406B $0.860B
CONMED Corporation is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology. The Company distributes its products worldwide from several manufacturing locations.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $67.932B 22.63
McKesson (MCK) United States $25.837B 10.20
Align Technology (ALGN) United States $22.714B 61.32
AmerisourceBergen (ABC) United States $17.962B 12.76
Laboratory Of America Holdings (LH) United States $17.126B 16.01
Cooper (COO) United States $16.398B 28.35
Straumann Holding AG (SAUHF) Switzerland $13.579B 0.00
Cardinal Health (CAH) United States $13.434B 8.70
DENTSPLY SIRONA (XRAY) United States $13.320B 27.77
Henry Schein (HSIC) United States $10.335B 17.38
West Pharmaceutical Services (WST) United States $8.958B 41.61
Merit Medical Systems (MMSI) United States $3.097B 32.18
Patterson (PDCO) United States $1.979B 14.83
Atrion (ATRI) United States $1.460B 41.69
STAAR Surgical (STAA) United States $1.382B 94.15
Antares Pharma (ATRS) United States $0.493B 0.00
Lifevantage (LFVN) United States $0.164B 21.72
Invacare (IVC) United States $0.157B 0.00
Endologix (ELGX) United States $0.118B 0.00
Pro-Dex (PDEX) United States $0.058B 17.78